Learn more

INST BIOCHEMII I BIOFIZYKI PAN

Overview
  • Total Patents
    79
  • GoodIP Patent Rank
    63,480
About

INST BIOCHEMII I BIOFIZYKI PAN has a total of 79 patent applications. Its first patent ever was published in 1995. It filed its patents most often in Poland, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are JE IL PHARMACEUTICAL CO LTD, AICURIS ANTI-INFECTIVE CURES GMBH and ROCHE OLIVIER.

Patent filings per year

Chart showing INST BIOCHEMII I BIOFIZYKI PANs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Zielenkiewicz Piotr 25
#2 Odolczyk Norbert 20
#3 Edelman Aleksander 20
#4 Tondelier Danielle 20
#5 Fritsch Janine 20
#6 Wieczorek Grzegorz 17
#7 Bardowski Jacek 10
#8 Sirko Agnieszka 10
#9 Stachyra Anna 7
#10 Kulikowski Tadeusz 6

Latest patents

Publication Filing date Title
AU2015201412A1 Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction
WO2013107526A2 Synthetic genes encoding peptide fragments of natural myelin proteins for induction of oral tolerance, dna fragment comprising these genes, means of obtaining these peptides in a microbial (bacterial) system and their medical application
WO2013104424A1 Synthetic genes encoding peptide fragments of natural myelin proteins for induction of oral tolerance, dna fragment comprising these genes, means of obtaining these peptides in a microbial (bacterial) system and their medical application
WO2013102492A1 Synthetic genes encoding peptide fragments of natural myelin proteins for induction of oral tolerance, dna fragment comprising these genes, means of obtaining these peptides in a microbial (bacterial) system and their medical application
CN104478800A Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction
PL222497B1 Virus-like vector particle, process for preparation and use thereof and pharmaceutical composition containing the virus-like vector particle
PL387780A1 Virus-like vector particle, method of its production, application of the virus-like vector particle and the farmaceutical composition containing the virus-like vector particle,
PL386397A1 Method of blocking the action of RAGE receptor, peptide blocking the reaction of peptide A� with the domain V of that receptor, and its application
PL386238A1 New asymmetric substituted derivatives of 1,4,7- triazacyclononane, method of their manufacturing, their application and the protein chip and method of the protein immobilization
PL382448A1 Trimethylamine derivatives of poly-cis and poly-trans line isoprene oligomers, method for their production and use
AU2006337723A1 Method of hydrolysis of peptide bond
PL360930A1 New derivatives of benzotriazole as inhibitors of ntpase/ helicase viruses belonging to the flaviviride family and antiviral agents
PL348789A1 Novel gene, method of obtaining same, amylolythic enzyme encoded by that gene and application thereof
PL346996A1 Novel salts of halogenethylguanines as inhibitors of viruses of Flaviviridae family as well as therapeutic agents exhibiting antiviral properties
PL346747A1 Method of simultaneously obtaining a bacterial biomass and lactic acid
PL346746A1 Method of simultaneously obtaining a bacterial biomass and amylolythic enzymes
PL346207A1 Method of obtaining purified human prolactin
PL339115A1 Novel mutated ccpa regulator gene
PL339113A1 Novel bacterial strain of lactococcus lactis and method of obtaining same
PL339114A1 Method of fermenting lactose by bacteria of lactococcus lactis type in particular plasmidefree ones